March 12, 2020 / 4:10 PM / 24 days ago

BRIEF-Evoke Pharma Reports Q4 Loss Per Share Of $0.06

March 12 (Reuters) - Evoke Pharma Inc:

* EVOKE PHARMA REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.06

* AS OF DECEMBER 31, 2019, COMPANY’S CASH AND CASH EQUIVALENTS WERE APPROXIMATELY $5.7 MILLION

* EXPECT CURRENT CASH TO SUPPORT OPERATIONS INTO Q3 OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below